Clinical trial
Study Evaluating HKI-272 in Tumors
NCT00146172
Study timeline
Study start (actual)2003-11-01Date precision: month
Registry last updated2018-09-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Neoplasmsunresolved
Interventions
neratinibDRUG · verified · RxNorm: neratinib
Sponsors & collaborators
Puma Biotechnology, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00146172 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.